| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 167,200 | 165,923 | 119,323 | 149,757 | | Cost of Revenue | 106,299 | 104,685 | 88,610 | 97,251 | | | Gross Profit | 60,901 | 61,238 | 30,713 | 52,506 | | | Operating Expenses | | Research Development | 4,972 | 5,161 | 4,864 | 4,952 | | Selling General and Administrative | 34,913 | 37,168 | 36,187 | 40,123 | | Non Recurring |
-
|
-
|
-
| 2,898 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 21,016 | 18,909 | (10,338) | 4,533 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| (38) | 102 | 764 | | Earnings Before Interest And Taxes | 21,016 | 18,850 | (10,429) | 4,811 | | Interest Expense |
-
|
-
|
-
| 381 | | Income Before Tax | 21,016 | 18,850 | (10,429) | 4,430 | | Income Tax Expense | 8,258 | 8,167 | (2,020) | 2,592 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 12,544 | 10,683 | (8,409) | 1,838 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 12,758 | 10,683 | (8,409) | 1,838 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $12,758 | $10,683 | ($8,409) | $1,838 |
|
0.51% Nasdaq 
Income Statement
